BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28235567)

  • 21. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
    Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
    Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.
    Engeland K
    Cell Death Differ; 2018 Jan; 25(1):114-132. PubMed ID: 29125603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3' end processing through p21, NPAT and CDK9.
    Pirngruber J; Johnsen SA
    Oncogene; 2010 May; 29(19):2853-63. PubMed ID: 20190802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
    Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
    Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of p53-Independent Apoptosis and G1 Cell Cycle Arrest by Fucoidan in HCT116 Human Colorectal Carcinoma Cells.
    Park HY; Park SH; Jeong JW; Yoon D; Han MH; Lee DS; Choi G; Yim MJ; Lee JM; Kim DH; Kim GY; Choi IW; Kim S; Kim HS; Cha HJ; Choi YH
    Mar Drugs; 2017 May; 15(6):. PubMed ID: 28555064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
    Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
    Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
    Xu Y; Yan W; Chen X
    Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
    Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
    Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
    He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
    Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.
    Kim EJ; Kho JH; Kang MR; Um SJ
    Mol Cell; 2007 Oct; 28(2):277-90. PubMed ID: 17964266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.
    Yin Y; Zhu A; Jin YJ; Liu YX; Zhang X; Hopkins KM; Lieberman HB
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8864-9. PubMed ID: 15184659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-Activation of PKC-δ by CRIF1 Modulates Oxidative Stress in Bone Marrow Multipotent Mesenchymal Stromal Cells after Irradiation by Phosphorylating NRF2 Ser40.
    Chen L; Ran Q; Xiang Y; Xiang L; Chen L; Li F; Wu J; Wu C; Li Z
    Theranostics; 2017; 7(10):2634-2648. PubMed ID: 28819452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. eRNAs are required for p53-dependent enhancer activity and gene transcription.
    Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
    Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2.
    Nagar H; Kim S; Lee I; Choi SJ; Piao S; Jeon BH; Shong M; Kim CS
    PLoS One; 2021; 16(8):e0256646. PubMed ID: 34437633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle arrest of Jurkat cells by leukemic bone marrow stromal cells: possible mechanisms and involvement of CRIF1.
    Zhang X; Ran Q; Li Z; Liu Y; Liang X; Chen X
    Transplant Proc; 2011 Sep; 43(7):2770-3. PubMed ID: 21911160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.
    Cannell IG; Merrick KA; Morandell S; Zhu CQ; Braun CJ; Grant RA; Cameron ER; Tsao MS; Hemann MT; Yaffe MB
    Cancer Cell; 2015 Nov; 28(5):623-637. PubMed ID: 26602816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.